Cargando…
Enhanced Immunomodulation, Anti-Apoptosis, and Improved Tear Dynamics of (PEG)-BHD1028, a Novel Adiponectin Receptor Agonist Peptide, for Treating Dry Eye Disease
Dry eye disease (DED) is characterized by impaired tear dynamics, leading to complex pathophysiological conditions. (PEG)-BHD1028, a peptide agonist to AdipoRs, was evaluated as a potential therapeutic agent for DED based on the reported physiological function of adiponectin, including anti-inflamma...
Autores principales: | Lee, In-Kyung, Yoon, Kyung-Chul, Kang, Seong-Soo, Seon, Su-Kyung, Lee, Kwanghyun, Kim, Brian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863990/ https://www.ncbi.nlm.nih.gov/pubmed/36678707 http://dx.doi.org/10.3390/pharmaceutics15010078 |
Ejemplares similares
-
PEG-BHD1028 Peptide Regulates Insulin Resistance and Fatty Acid β-Oxidation, and Mitochondrial Biogenesis by Binding to Two Heterogeneous Binding Sites of Adiponectin Receptors, AdipoR1 and AdipoR2
por: Lee, In Kyung, et al.
Publicado: (2021) -
Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome
por: Kook, Kyung Yun, et al.
Publicado: (2020) -
Tear Neuromediators in Subjects with and without Dry Eye According to Ocular Sensitivity
por: Yoon, Hyeon-Jeong, et al.
Publicado: (2022) -
A novel TRPM8 agonist relieves dry eye discomfort
por: Yang, Jee Myung, et al.
Publicado: (2017) -
Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone
por: Lee, Ji Hwan, et al.
Publicado: (2014)